BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9145417)

  • 1. Identification of casoxin C, an ileum-contracting peptide derived from bovine kappa-casein, as an agonist for C3a receptors.
    Takahashi M; Moriguchi S; Suganuma H; Shiota A; Tani F; Usui H; Kurahashi K; Sasaki R; Yoshikawa M
    Peptides; 1997; 18(3):329-36. PubMed ID: 9145417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the ileum-contracting mechanisms and identification as a complement C3a receptor agonist of oryzatensin, a bioactive peptide derived from rice albumin.
    Takahashi M; Moriguchi S; Ikeno M; Kono S; Ohata K; Usui H; Kurahashi K; Sasaki R; Yoshikawa M
    Peptides; 1996; 17(1):5-12. PubMed ID: 8822503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of oryzatensin: a novel bioactive peptide with ileum-contracting and immunomodulating activities derived from rice albumin.
    Takahashi M; Moriguchi S; Yoshikawa M; Sasaki R
    Biochem Mol Biol Int; 1994 Aug; 33(6):1151-8. PubMed ID: 7804141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid antagonist peptides derived from kappa-casein.
    Chiba H; Tani F; Yoshikawa M
    J Dairy Res; 1989; 56(3):363-6. PubMed ID: 2760302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The active site of human C4a anaphylatoxin.
    Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
    Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum.
    Zadina JE; Kastin AJ; Kersh D; Wyatt A
    Life Sci; 1992; 51(11):869-85. PubMed ID: 1355851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of opioid antagonist peptides derived from human lactoferrin.
    Tani F; Iio K; Chiba H; Yoshikawa M
    Agric Biol Chem; 1990 Jul; 54(7):1803-10. PubMed ID: 1369293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.
    Hugli TE; Erickson BW
    Proc Natl Acad Sci U S A; 1977 May; 74(5):1826-30. PubMed ID: 266705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mu and kappa opioid receptor modulation of 5-HT3 and NK-3 receptor-evoked release of acetylcholine from the guinea-pig ileum myenteric plexus.
    Fox AJ; Morton IK
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):8-15. PubMed ID: 1723152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.
    Lung FD; Meyer JP; Lou BS; Xiang L; Li G; Davis P; DeLeon IA; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Jun; 39(13):2456-60. PubMed ID: 8691442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3a-induced contraction of guinea pig ileum consists of two components: fast histamine-mediated and slow prostanoid-mediated.
    del Balzo U; Polley MJ; Levi R
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1003-9. PubMed ID: 2467976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The active site of C3a anaphylatoxin.
    Caporale LH; Tippett PS; Erickson BW; Hugli TE
    J Biol Chem; 1980 Nov; 255(22):10758-63. PubMed ID: 6968751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of a low molecular weight agonist peptide for complement C3a receptor into soybean proglycinin A1aB1b subunit by site-directed mutagenesis.
    Takenaka Y; Utsumi S; Yoshikawa M
    Biosci Biotechnol Biochem; 2001 May; 65(5):1202-5. PubMed ID: 11440140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [2',6'-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective kappa opioid antagonists.
    Lu Y; Nguyen TM; Weltrowska G; Berezowska I; Lemieux C; Chung NN; Schiller PW
    J Med Chem; 2001 Sep; 44(19):3048-53. PubMed ID: 11543672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of cyclic beta-casomorphin-5 analogues.
    Schmidt R; Neubert K; Barth A; Liebmann C; Schnittler M; Chung NN; Schiller PW
    Peptides; 1991; 12(6):1175-80. PubMed ID: 1667685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactive peptide derived from in vitro proteolysis of bovine beta-lactoglobulin and its effect on smooth muscle.
    Pihlanto-Leppälä A; Paakkari I; Rinta-Koski M; Antila P
    J Dairy Res; 1997 Feb; 64(1):149-55. PubMed ID: 9120074
    [No Abstract]   [Full Text] [Related]  

  • 18. Contraction of guinea pig lung by synthetic oligopeptides related to human C3a.
    Huey R; Erickson BW; Bloor CM; Hugli TE
    Immunopharmacology; 1984 Aug; 8(1):37-45. PubMed ID: 6333413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
    Grider JR; Makhlouf GM
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
    Zadina JE; Kastin AJ; Ge LJ; Hackler L
    Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.